DS
OACC

David Shaw’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

David Shaw’s Portfolio OACC Stock Details OACC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.23M Hold
861,625
– – ﹤0.01% 1884
2026
Q1 		$9.15M Hold
861,625
– – 0.01% 1718
2025
Q4 		$9.16M Hold
861,625
– – 0.01% 1840
2025
Q3 		$9.02M Hold
861,625
– – 0.01% 1765
2025
Q2 		$9.03M Hold
861,625
– – 0.01% 1574
2025
Q1 		$8.79M Buy
+861,625
New +$8.65M 0.01% 1494

Other funds holding OACC

AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.37B AUM 26.91% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.03B AUM 47.81% 1-Year Est. Return
BGGS
Boussard & Gavaudan Gestion SAS Paris, France $1.99B AUM
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

David Shaw's OACC Position: Q2 2026 in Review

David Shaw held its Oaktree Acquisition Corp III Life Sciences (OACC) position steady in Q2 2026 at 861,625 shares worth $9.23M. The position accounts for ﹤0.01% of the portfolio, ranked #1884.

David Shaw first reported a position in OACC in Q1 2025 and has held it in 6 quarters since. 50 funds tracked by Wall St. Rank hold OACC as of Q2 2026.

  • David Shaw held 861,625 shares of Oaktree Acquisition Corp III Life Sciences worth $9.23M as of Q2 2026.
  • David Shaw left its Oaktree Acquisition Corp III Life Sciences share count unchanged in Q2 2026.
  • Oaktree Acquisition Corp III Life Sciences made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #1884 holding.
  • David Shaw first reported a position in Oaktree Acquisition Corp III Life Sciences in Q1 2025 and has held it in 6 quarters since.
  • 50 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.